Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
01/18/2006 | EP1615883A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
01/18/2006 | EP1615881A2 Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
01/18/2006 | EP1615878A2 Compounds, compositions and methods |
01/18/2006 | EP1615643A1 4-phenyl-piperidine compounds and their use as modulators of opioid receptors |
01/18/2006 | EP1615637A1 Pharmaceutical use of substituted 1,2,4-triazoles |
01/18/2006 | EP1615634A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
01/18/2006 | EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
01/18/2006 | EP1194410B1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
01/18/2006 | CN1723199A 1,4-disubstituted piperidine derivatives and their use as 11-beta hsd1 inhibitors |
01/18/2006 | CN1723198A Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
01/18/2006 | CN1721417A New pyrrolidine and thiazolidine compounds, a process for their preparation and pharmaceutical compositions containing them |
01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
01/18/2006 | CN1721407A New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
01/18/2006 | CN1720913A Water-soluble triazole fungicide |
01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
01/18/2006 | CN1237055C 三唑衍生物 Triazole derivatives |
01/18/2006 | CN1237054C Insecticidal and acaricidal agents |
01/18/2006 | CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
01/17/2006 | US6987188 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders |
01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
01/17/2006 | US6987120 Pharmaceutical compounds |
01/17/2006 | US6987114 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
01/17/2006 | CA2118812C 5-ht4 receptor antagonists |
01/12/2006 | WO2006004741A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
01/12/2006 | WO2006004684A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
01/12/2006 | WO2006003378A1 Azine-carboxamides as anti-cancer agent |
01/12/2006 | WO2006003276A1 Substituted indazoles, compositions containing same, preparation and use |
01/12/2006 | WO2006003150A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
01/12/2006 | WO2006003146A1 Quinazolinone derivatives as parp inhibitors |
01/12/2006 | WO2006002956A1 Piperidine derivatives and their use as glycine transporter inhibitors |
01/12/2006 | WO2006002875A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
01/12/2006 | WO2006002874A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain 1, 4, 7, 10-tertraazacyclodecan-1, 4, 7-triacetic acid chelating moiety with polyhydroxylated substituents |
01/12/2006 | WO2006002873A2 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri ) |
01/12/2006 | WO2005117908A3 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases |
01/12/2006 | WO2005105079A3 Novel imidazoles |
01/12/2006 | WO2005100320A3 Crystalline 2-amino-3-cyanoquinoline derivatives, process of their preparation and pharmaceutical compositions containing them |
01/12/2006 | WO2005080343A3 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators |
01/12/2006 | US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
01/12/2006 | US20060009503 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
01/12/2006 | US20060009497 Novel tetrahydropyridine derivatives as renin inhibitors |
01/12/2006 | US20060009481 Arylindenopyridines and related therapeutic and prophylactic methods |
01/12/2006 | US20060009472 Substituted imidazole derivatives |
01/12/2006 | US20060009467 Novel gamma secretase inhibitors |
01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
01/12/2006 | US20060009455 especially blood coagulation factor XIa and plasma kallikrein; e.g. 4-aminomethyl-[2-phenyl-1-(4-phenyl-pyridin-2-yl)-ethyl]-trans cyclohexanecarboxamide; anticoagulant, antiinflammatory agent; |
01/12/2006 | US20060009453 Protein kinase modulators and method of use |
01/12/2006 | US20060009439 Novel physiologically active substances |
01/12/2006 | US20060008835 PNA monomer and precursor |
01/12/2006 | DE102004031100A1 Anthranilamide Anthranilamides |
01/12/2006 | CA2572874A1 Urea derivative |
01/12/2006 | CA2570169A1 Azine-carboxamides as anti-cancer agent |
01/12/2006 | CA2569826A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
01/12/2006 | CA2568835A1 Quinazolinone derivatives as parp inhibitors |
01/12/2006 | CA2567744A1 Substituted indazoles, compositions containing same, preparation and use |
01/12/2006 | CA2564996A1 3-aryl-5,6-disubstituted pyridazines |
01/11/2006 | EP1614688A1 Phenylazole compound, production process, and antioxidant drug |
01/11/2006 | EP1614687A1 Process for the preparation of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one derivatives and their application in the synthesis of ivabradine and its pharmaceutically acceptable salts |
01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
01/11/2006 | EP1614676A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
01/11/2006 | EP1614419A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
01/11/2006 | EP1613634A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
01/11/2006 | EP1613624A2 Novel compounds having an antibacterial activity |
01/11/2006 | EP1613618A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA- sb A /sb RECEPTOR COMPLEX |
01/11/2006 | EP1613607A1 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds |
01/11/2006 | EP1613603A2 Migrastatin analogs and uses thereof |
01/11/2006 | EP1613597A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
01/11/2006 | EP1613594A1 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
01/11/2006 | EP1613590A2 4-(3,4-disubstituted phenyl)-pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors |
01/11/2006 | EP1613315A1 Quinoline-2-one-derivatives for the treatment of airways diseases |
01/11/2006 | EP1613313A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
01/11/2006 | EP1613311A2 Hif-1 inhibitors |
01/11/2006 | EP1613156A1 N-phenyl- " (4-pyridyl)- azinyl!amine derivatives as plant protection agents |
01/11/2006 | EP1421082B1 piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
01/11/2006 | EP1340753B1 Carbamate derivatives, process for producing the same and use thereof |
01/11/2006 | EP1131315B1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
01/11/2006 | EP1028944B1 Fluorinated naphthalene derivatives and their use in liquid crystal mixtures |
01/11/2006 | EP0930883B1 Neurotrophin antagonists for the treatment of epilepsy, alzheimer's disease and pain |
01/11/2006 | CN1720245A Oxime ester photoinitiators with heteroaromatic groups |
01/11/2006 | CN1720244A Anthranilic acid amide derivatives and their pharmaceutical use |
01/11/2006 | CN1720234A Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives |
01/11/2006 | CN1720233A Pesticidal sulphonylaminopyrazoles |
01/11/2006 | CN1720231A Substituted dihydrophenanthridinesulfonamides |
01/11/2006 | CN1720224A Vasculostatic agents and methods of use thereof |
01/11/2006 | CN1720047A PgD2 receptor antagonists for the treatment of inflammatory diseases |
01/11/2006 | CN1720043A Non-nucleoside reverse transcriptase inhibitors |
01/10/2006 | US6984735 Reacting a dihalaromatic compound with sulfoxide |
01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
01/10/2006 | US6984649 Pyridine derivatives |
01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
01/10/2006 | US6984643 2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists |
01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
01/10/2006 | US6984640 Antiparasitic artemisinin derivatives (endoperoxides) |
01/10/2006 | US6984632 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives |
01/10/2006 | CA2327758C (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
01/10/2006 | CA2223918C Pyrrole derivatives and medicinal composition |
01/10/2006 | CA2163520C L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
01/10/2006 | CA2129990C Benzodiazepin derivatives useful as cck-receptor antagonists |